Publications by authors named "Daniel Putzer"

Claim this Profile
M
Minimal invasive treatment of liver and kidney metastasis in mucosal melanoma of the right inferior turbinate.
Pietro G Lacaita, Reto Bale, Paolo Lucciarini, Van Anh Nguyen, Martin Freund, Daniel Putzer

Radiol Case Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superb microvascular ultrasound is a promising non-invasive diagnostic tool to assess a ventriculoperitoneal shunt system function: a feasibility study.
Konstantin Brawanski, Ondra Petr, Christian Preuss Hernandez, Nikolaus Kögl, Claudius Thomé, Daniel Putzer

Neurosurg Rev· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Maria Effenberger, Silvio Waschina, Christina Bronowski, Gregor Sturm, Oronzo Tassiello, Daniel Putzer

Hepatol Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-11 drives human and mouse alcohol-related liver disease.
Maria Effenberger, Anissa A Widjaja, Felix Grabherr, Benedikt Schaefer, Christoph Grander, Daniel Putzer

Gut· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of Stereotactic Radiofrequency Ablation (SRFA) for Malignant Liver Tumors: Novice versus Experienced Operators.
Peter Schullian, Gregor Laimer, Edward Johnston, Daniel Putzer, Gernot Eberle

Biology (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Peter Schullian, Edward Johnston, Gregor Laimer, Yannick Scharll, Daniel Putzer

HPB (Oxford)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas.
Gregor Laimer, Peter Schullian, Yannick Scharll, Daniel Putzer, Gernot Eberle

Int J Hyperthermia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Peter Schullian, Gregor Laimer, Edward Johnston, Daniel Putzer, Gernot Eberle

Int J Hyperthermia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
Eva Braunwarth, Peter Schullian, Moritz Kummann, Simon Reider, Daniel Putzer

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
Gregor Laimer, Nikolai Jaschke, Peter Schullian, Daniel Putzer, Gernot Eberle

Eur Radiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
Gregor Laimer, Nikolai Jaschke, Peter Schullian, Daniel Putzer, Gernot Eberle

Eur Radiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Peter Schullian, Edward Johnston, Gregor Laimer, Daniel Putzer, Gernot Eberle

Cardiovasc Intervent Radiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Peter Schullian, Edward Johnston, Gregor Laimer, Daniel Putzer, Gernot Eberle

Cardiovasc Intervent Radiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiofrequency ablation of a variety of liver masses in children.
Benjamin Hetzer, Georg-Friedrich Vogel, Andreas Entenmann, Michel Heil, Peter Schullian, Daniel Putzer

Int J Hyperthermia· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Peter Schullian, Edward Johnston, Gregor Laimer, Daniel Putzer, Gernot Eberle

Eur Radiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Peter Schullian, Edward W Johnston, Daniel Putzer, Gregor Laimer, Gregor Waroschitz

Eur J Surg Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
Peter Schullian, Edward Johnston, Gregor Laimer, Daniel Putzer, Gernot Eberle

Int J Hyperthermia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can accurate evaluation of the treatment success after radiofrequency ablation of liver tumors be achieved by visual inspection alone? Results of a blinded assessment with 38 interventional oncologists.
Gregor Laimer, Peter Schullian, Daniel Putzer, Gernot Eberle, S Nahum Goldberg

Int J Hyperthermia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Peter Schullian, Gregor Laimer, Daniel Putzer, Elliot Levy, Eva Braunwarth

Eur J Surg Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life analysis after stereotactic radiofrequency ablation of liver tumors.
Peter Schullian, Anja Gertl, Gregor Laimer, Daniel Putzer, Uwe Siebert

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
Peter Schullian, Daniel Putzer, Gernot Eberle, Gregor Laimer, Reto Bale

J Vasc Interv Radiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEN: Advancement in Diagnosis and Minimally Invasive Therapy.
Daniel Putzer, Peter Schullian, Werner Jaschke, Reto Bale

Rofo· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Gregor Laimer, Peter Schullian, Nikolai Jaschke, Daniel Putzer, Gernot Eberle

Eur Radiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiofrequency Ablation of an Unresectable Intrahepatic Cholangiocarcinoma (ICC): Transforming an Aggressive Disease into a Chronic Condition.
Gregor Laimer, Nikolai Jaschke, Maximilian Gottardis, Peter Schullian, Daniel Putzer

Cardiovasc Intervent Radiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Peter Schullian, Edward W Johnston, Daniel Putzer, Gernot Eberle, Gregor Laimer

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis